405 related articles for article (PubMed ID: 10854289)
1. Impaired proteasome function in Alzheimer's disease.
Keller JN; Hanni KB; Markesbery WR
J Neurochem; 2000 Jul; 75(1):436-9. PubMed ID: 10854289
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
Keck S; Nitsch R; Grune T; Ullrich O
J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
[TBL] [Abstract][Full Text] [Related]
3. Does proteasome inhibition play a role in mediating neuropathology and neuron death in Alzheimer's disease?
Ding Q; Keller JN
J Alzheimers Dis; 2003 Jun; 5(3):241-5. PubMed ID: 12897408
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the proteasome to the alpha-secretase pathway in Alzheimer's disease.
Marambaud P; Rieunier F; Wilk S; Martinez J; Checler F
Adv Exp Med Biol; 1997; 421():267-72. PubMed ID: 9330707
[No Abstract] [Full Text] [Related]
5. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease.
Mutisya EM; Bowling AC; Beal MF
J Neurochem; 1994 Dec; 63(6):2179-84. PubMed ID: 7964738
[TBL] [Abstract][Full Text] [Related]
6. Role of the proteasome in Alzheimer's disease.
Checler F; da Costa CA; Ancolio K; Chevallier N; Lopez-Perez E; Marambaud P
Biochim Biophys Acta; 2000 Jul; 1502(1):133-8. PubMed ID: 10899438
[TBL] [Abstract][Full Text] [Related]
7. Characterization of chronic low-level proteasome inhibition on neural homeostasis.
Ding Q; Dimayuga E; Martin S; Bruce-Keller AJ; Nukala V; Cuervo AM; Keller JN
J Neurochem; 2003 Jul; 86(2):489-97. PubMed ID: 12871590
[TBL] [Abstract][Full Text] [Related]
8. Proteasome degradation of brain cytosolic tau in Alzheimer's disease.
Yen SS
Int J Clin Exp Pathol; 2011 Apr; 4(4):385-402. PubMed ID: 21577325
[TBL] [Abstract][Full Text] [Related]
9. The 20S proteasome isolated from Alzheimer's disease brain shows post-translational modifications but unchanged proteolytic activity.
Gillardon F; Kloss A; Berg M; Neumann M; Mechtler K; Hengerer B; Dahlmann B
J Neurochem; 2007 Jun; 101(6):1483-90. PubMed ID: 17286585
[TBL] [Abstract][Full Text] [Related]
10. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
[TBL] [Abstract][Full Text] [Related]
11. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
Hänggi J; Streffer J; Jäncke L; Hock C
J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
[TBL] [Abstract][Full Text] [Related]
12. Defective ubiquitination of cerebral proteins in Alzheimer's disease.
López Salon M; Morelli L; Castaño EM; Soto EF; Pasquini JM
J Neurosci Res; 2000 Oct; 62(2):302-10. PubMed ID: 11020223
[TBL] [Abstract][Full Text] [Related]
13. Selective proteasomal dysfunction in the hippocampal CA1 region after transient forebrain ischemia.
Asai A; Tanahashi N; Qiu JH; Saito N; Chi S; Kawahara N; Tanaka K; Kirino T
J Cereb Blood Flow Metab; 2002 Jun; 22(6):705-10. PubMed ID: 12045669
[TBL] [Abstract][Full Text] [Related]
14. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease.
Lovell MA; Xie C; Markesbery WR
Neurology; 1998 Dec; 51(6):1562-6. PubMed ID: 9855502
[TBL] [Abstract][Full Text] [Related]
15. The proteasome in brain aging.
Keller JN; Gee J; Ding Q
Ageing Res Rev; 2002 Apr; 1(2):279-93. PubMed ID: 12039443
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-proteasome pathway: on protein death and cell life.
Ciechanover A
EMBO J; 1998 Dec; 17(24):7151-60. PubMed ID: 9857172
[No Abstract] [Full Text] [Related]
17. The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death.
Ciechanover A; Schwartz AL
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):2727-30. PubMed ID: 9501156
[No Abstract] [Full Text] [Related]
18. High Expression of Nicotinamide N-Methyltransferase in Patients with Sporadic Alzheimer's Disease.
Kocinaj A; Chaudhury T; Uddin MS; Junaid RR; Ramsden DB; Hondhamuni G; Klamt F; Parsons L; Parsons RB
Mol Neurobiol; 2021 Apr; 58(4):1769-1781. PubMed ID: 33387303
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactive parvalbumin concentrations in parahippocampal gyrus decrease in patients with Alzheimer's disease.
Inaguma Y; Shinohara H; Inagaki T; Kato K
J Neurol Sci; 1992 Jul; 110(1-2):57-61. PubMed ID: 1506869
[TBL] [Abstract][Full Text] [Related]
20. Immunoproteasome and LMP2 polymorphism in aged and Alzheimer's disease brains.
Mishto M; Bellavista E; Santoro A; Stolzing A; Ligorio C; Nacmias B; Spazzafumo L; Chiappelli M; Licastro F; Sorbi S; Pession A; Ohm T; Grune T; Franceschi C
Neurobiol Aging; 2006 Jan; 27(1):54-66. PubMed ID: 16298241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
